Skip to main content
Top
Published in: Annals of Hematology 2/2015

01-02-2015 | Original Article

DNA topoisomerase IIβ as a molecular switch in neural differentiation of mesenchymal stem cells

Authors: Sevim Isik, Merve Zaim, Mehmet Taha Yildiz, Yesim Negis, Tuba Kunduraci, Nihal Karakas, Gulsum Arikan, Guven Cetin

Published in: Annals of Hematology | Issue 2/2015

Login to get access

Abstract

Two isoforms of DNA topoisomerase II (topo II) have been identified in mammalian cells, named topo IIα and topo IIβ. Topo IIα plays an essential role in segregation of daughter chromosomes and thus for cell proliferation in mammalian cells. Unlike its isozyme topo IIα, topo IIβ is greatly expressed upon terminal differentiation of neuronal cells. Although there have been accumulating evidence about the crucial role of topo IIβ in neural development through activation or repression of developmentally regulated genes at late stages of neuronal differentiation, there have been no reports that analyzed the roles of topo IIβ in the neural trans differentiation process of multipotent stem cells. Terminal differentiation of neurons and transdifferentiation of Mesenchymal Stem Cells (MSCs) are two distinct processes. Therefore, the functional significance of topo IIβ may also be different in these differentiation systems. MSC transdifferentiation into neuron-like cells represents an useful model to further validate the role of topo IIβ in neuronal differentiation. The aim of this study is to evaluate the subset of genes that are regulated in neural transdifferentiation of bone marrow-derived human MSCs (BM-hMSCs) in vitro and find genes related with topo IIβ. For this purpose, topo IIβ was silenced by specific small interfering RNAs in hMSCs and cells were induced to differentiate into neuron-like cells. Differentiation and silencing of topo IIβ were monitored by real-time cell analysis and also expressions of topo II isoforms were analyzed. Change in transcription patterns of genes upon topo IIβ silencing was identified by DNA microarray analysis, and apparently genes involved in regulation of several ion channels and transporters, vesicle function, and cell calcium metabolism were particularly affected by topo IIβ silencing suggesting that topoIIβ silencing can significantly alter the gene expression pattern of genes involved in variety of biological processes and signal transduction pathways including transcription, translation, cell trafficking, vesicle function, transport, cell morphology, neuron guidance, growth, polarity, and axonal growth. It appears that the deregulation of these pathways may contribute to clarify the further role of topo IIβ in neural differentiation.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bak M, Hansen C, Tommerup N, Larsen LA (2003) The Hedgehog signaling pathway—implications for drug targets in cancer and neurodegenerative disorders. Pharmacogenomics 4(4):411–429PubMedCrossRef Bak M, Hansen C, Tommerup N, Larsen LA (2003) The Hedgehog signaling pathway—implications for drug targets in cancer and neurodegenerative disorders. Pharmacogenomics 4(4):411–429PubMedCrossRef
2.
go back to reference Barzilay R, Melamed E, Offen D (2009) Introducing transcription factors to multipotent mesenchymal stem cells: making trans differentiation possible. Stem Cells 27(10):2509–2515PubMedCrossRef Barzilay R, Melamed E, Offen D (2009) Introducing transcription factors to multipotent mesenchymal stem cells: making trans differentiation possible. Stem Cells 27(10):2509–2515PubMedCrossRef
3.
go back to reference Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8(4):315–317PubMedCrossRef Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8(4):315–317PubMedCrossRef
4.
go back to reference Edward H, Koo RK (2004) Potential role of presenilin-regulated signaling pathways in sporadic neurodegeneration. Nat Med 10:S26–S33CrossRef Edward H, Koo RK (2004) Potential role of presenilin-regulated signaling pathways in sporadic neurodegeneration. Nat Med 10:S26–S33CrossRef
5.
go back to reference Ito D, Walker JR, Thompson CS, Moroz I, Lin W, Veselits ML, Hakim AM, Fienberg AA, Thinakaran G (2004) Characterization of stanniocalcin 2, a novel target of the mammalian unfolded protein response with cytoprotective properties. Mol Cell Biol 24(21):9456–9469PubMedCentralPubMedCrossRef Ito D, Walker JR, Thompson CS, Moroz I, Lin W, Veselits ML, Hakim AM, Fienberg AA, Thinakaran G (2004) Characterization of stanniocalcin 2, a novel target of the mammalian unfolded protein response with cytoprotective properties. Mol Cell Biol 24(21):9456–9469PubMedCentralPubMedCrossRef
6.
go back to reference Ju BG, Lunyak VV, Perissi V, Garcia-Bassets I, Rose DW, Glass CK, Rosenfeld MG (2006) A topoisomerase IIbeta-mediated dsDNA break required for regulated transcription. Science 312(5781):1798–1802PubMedCrossRef Ju BG, Lunyak VV, Perissi V, Garcia-Bassets I, Rose DW, Glass CK, Rosenfeld MG (2006) A topoisomerase IIbeta-mediated dsDNA break required for regulated transcription. Science 312(5781):1798–1802PubMedCrossRef
7.
go back to reference Kamaci N, Emnacar T, Karakas N, Arikan G, Tsutsui K, Isik S (2011) Selective silencing of DNA topoisomerase IIbeta in human mesenchymal stem cells by siRNAs (small interfering RNAs). Cell Biol Int Rep 18(1):e00010, 2010CrossRef Kamaci N, Emnacar T, Karakas N, Arikan G, Tsutsui K, Isik S (2011) Selective silencing of DNA topoisomerase IIbeta in human mesenchymal stem cells by siRNAs (small interfering RNAs). Cell Biol Int Rep 18(1):e00010, 2010CrossRef
8.
go back to reference Kawano S, Miyaji M, Ichiyasu S, Tsutsui KM, Tsutsui K (2010) Regulation of DNA topoisomerase IIbeta through RNA-dependent association with heterogeneous nuclear ribonucleoprotein U (hnRNP U). J Biol Chem 285(34):26451–26460PubMedCentralPubMedCrossRef Kawano S, Miyaji M, Ichiyasu S, Tsutsui KM, Tsutsui K (2010) Regulation of DNA topoisomerase IIbeta through RNA-dependent association with heterogeneous nuclear ribonucleoprotein U (hnRNP U). J Biol Chem 285(34):26451–26460PubMedCentralPubMedCrossRef
9.
go back to reference Kondapi AK, Mulpuri N, Mandraju RK, Sasikaran B, Subba Rao K (2004) Analysis of age dependent changes of topoisomerase II alpha and beta in rat brain. Int J Dev Neurosci 22(1):19–30PubMedCrossRef Kondapi AK, Mulpuri N, Mandraju RK, Sasikaran B, Subba Rao K (2004) Analysis of age dependent changes of topoisomerase II alpha and beta in rat brain. Int J Dev Neurosci 22(1):19–30PubMedCrossRef
10.
go back to reference Kramer AH, Joos-Vandewalle J, Edkins AL, Frost CL, Prinsloo E (2014) Real-time monitoring of 3 T3-L1 preadipocyte differentiation using a commercially available electric cell-substrate impedance sensor system. Biochem Biophys Res Commun 443(4):1245–1250PubMedCrossRef Kramer AH, Joos-Vandewalle J, Edkins AL, Frost CL, Prinsloo E (2014) Real-time monitoring of 3 T3-L1 preadipocyte differentiation using a commercially available electric cell-substrate impedance sensor system. Biochem Biophys Res Commun 443(4):1245–1250PubMedCrossRef
11.
go back to reference LaFerla FM (2002) Calcium dyshomeostasis and intracellular signalling in Alzheimer’s disease. Nat Rev Neurosci 3(11):862–872PubMedCrossRef LaFerla FM (2002) Calcium dyshomeostasis and intracellular signalling in Alzheimer’s disease. Nat Rev Neurosci 3(11):862–872PubMedCrossRef
12.
go back to reference Lee HG, Casadesus G, Nunomura A, Zhu X, Castellani RJ, Richardson SL, Perry G, Felsher DW, Petersen RB, Smith MA (2009) The neuronal expression of MYC causes a neurodegenerative phenotype in a novel transgenic mouse. Am J Pathol 174(3):891–897PubMedCentralPubMedCrossRef Lee HG, Casadesus G, Nunomura A, Zhu X, Castellani RJ, Richardson SL, Perry G, Felsher DW, Petersen RB, Smith MA (2009) The neuronal expression of MYC causes a neurodegenerative phenotype in a novel transgenic mouse. Am J Pathol 174(3):891–897PubMedCentralPubMedCrossRef
13.
go back to reference Lelièvre EC, Plestant C, Boscher C, Wolff E, Mège R-M, Birbes H (2012) N-Cadherin mediates neuronal cell survival through Bim down-regulation. PLoS ONE 7(3):e33206PubMedCentralPubMedCrossRef Lelièvre EC, Plestant C, Boscher C, Wolff E, Mège R-M, Birbes H (2012) N-Cadherin mediates neuronal cell survival through Bim down-regulation. PLoS ONE 7(3):e33206PubMedCentralPubMedCrossRef
14.
go back to reference Long X, Olszewski M, Huang W, Kletzel M (2005) Neural cell differentiation in vitro from adult human bone marrow mesenchymal stem cells. Stem Cells Dev 14(1):65–69PubMedCrossRef Long X, Olszewski M, Huang W, Kletzel M (2005) Neural cell differentiation in vitro from adult human bone marrow mesenchymal stem cells. Stem Cells Dev 14(1):65–69PubMedCrossRef
15.
go back to reference Lu P, Blesch A, Tuszynski MH (2004) Induction of bone marrow stromal cells to neurons: differentiation, trans differentiation, or artifact? J Neurosci Res 77(2):174–191PubMedCrossRef Lu P, Blesch A, Tuszynski MH (2004) Induction of bone marrow stromal cells to neurons: differentiation, trans differentiation, or artifact? J Neurosci Res 77(2):174–191PubMedCrossRef
16.
go back to reference Lu P, Jones LL, Tuszynski MH (2005) BDNF-expressing marrow stromal cells support extensive axonal growth at sites of spinal cord injury. Exp Neurol 191(2):344–360PubMedCrossRef Lu P, Jones LL, Tuszynski MH (2005) BDNF-expressing marrow stromal cells support extensive axonal growth at sites of spinal cord injury. Exp Neurol 191(2):344–360PubMedCrossRef
17.
go back to reference Lyu YL, Lin CP, Azarova AM, Cai L, Wang JC, Liu LF (2006) Role of topoisomerase IIbeta in the expression of developmentally regulated genes. Mol Cell Biol 26(21):7929–7941PubMedCentralPubMedCrossRef Lyu YL, Lin CP, Azarova AM, Cai L, Wang JC, Liu LF (2006) Role of topoisomerase IIbeta in the expression of developmentally regulated genes. Mol Cell Biol 26(21):7929–7941PubMedCentralPubMedCrossRef
18.
go back to reference Lyu YL, Wang JC (2003) Aberrant lamination in the cerebral cortex of mouse embryos lacking DNA topoisomerase IIbeta. Proc Natl Acad Sci U S A 100(12):7123–7128PubMedCentralPubMedCrossRef Lyu YL, Wang JC (2003) Aberrant lamination in the cerebral cortex of mouse embryos lacking DNA topoisomerase IIbeta. Proc Natl Acad Sci U S A 100(12):7123–7128PubMedCentralPubMedCrossRef
19.
go back to reference Mackenzie F, Ruhrberg C (2012) Diverse roles for VEGF-A in the nervous system. Development 139(8):1371–1380PubMedCrossRef Mackenzie F, Ruhrberg C (2012) Diverse roles for VEGF-A in the nervous system. Development 139(8):1371–1380PubMedCrossRef
20.
go back to reference Nowacka MM, Obuchowicz E (2012) Vascular endothelial growth factor (VEGF) and its role in the central nervous system: a new element in the neurotrophic hypothesis of antidepressant drug action. Neuropeptides 46(1):1–10PubMedCrossRef Nowacka MM, Obuchowicz E (2012) Vascular endothelial growth factor (VEGF) and its role in the central nervous system: a new element in the neurotrophic hypothesis of antidepressant drug action. Neuropeptides 46(1):1–10PubMedCrossRef
21.
go back to reference Nur EKA, Meiners S, Ahmed I, Azarova A, Lin CP, Lyu YL, Liu LF (2007) Role of DNA topoisomerase IIbeta in neurite outgrowth. Brain Res 1154:50–60CrossRef Nur EKA, Meiners S, Ahmed I, Azarova A, Lin CP, Lyu YL, Liu LF (2007) Role of DNA topoisomerase IIbeta in neurite outgrowth. Brain Res 1154:50–60CrossRef
22.
go back to reference Reiner A, Albin RL, Anderson KD, D’Amato CJ, Penney JB, Young AB (1988) Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci 85(15):5733–5737PubMedCentralPubMedCrossRef Reiner A, Albin RL, Anderson KD, D’Amato CJ, Penney JB, Young AB (1988) Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci 85(15):5733–5737PubMedCentralPubMedCrossRef
24.
go back to reference Sanchez-Ramos J, Song S, Cardozo-Pelaez F, Hazzi C, Stedeford T, Willing A, Freeman TB, Saporta S, Janssen W, Patel N, Cooper DR, Sanberg PR (2000) Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol 164(2):247–256PubMedCrossRef Sanchez-Ramos J, Song S, Cardozo-Pelaez F, Hazzi C, Stedeford T, Willing A, Freeman TB, Saporta S, Janssen W, Patel N, Cooper DR, Sanberg PR (2000) Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol 164(2):247–256PubMedCrossRef
25.
go back to reference Sano K, Miyaji-Yamaguchi M, Tsutsui KM, Tsutsui K (2008) Topoisomerase IIbeta activates a subset of neuronal genes that are repressed in AT-rich genomic environment. PLoS One 3(12):e4103PubMedCentralPubMedCrossRef Sano K, Miyaji-Yamaguchi M, Tsutsui KM, Tsutsui K (2008) Topoisomerase IIbeta activates a subset of neuronal genes that are repressed in AT-rich genomic environment. PLoS One 3(12):e4103PubMedCentralPubMedCrossRef
26.
go back to reference Thakurela S, Garding A, Jung J, Schubeler D, Burger L, Tiwari VK (2013) Gene regulation and priming by topoisomerase IIalpha in embryonic stem cells. Nat Commun 4:2478PubMedCrossRef Thakurela S, Garding A, Jung J, Schubeler D, Burger L, Tiwari VK (2013) Gene regulation and priming by topoisomerase IIalpha in embryonic stem cells. Nat Commun 4:2478PubMedCrossRef
27.
go back to reference Tsutsui K, Tsutsui K, Hosoya O, Sano K, Tokunaga A (2001) Immunohistochemical analyses of DNA topoisomerase II isoforms in developing rat cerebellum. J Comp Neurol 431(2):228–239PubMedCrossRef Tsutsui K, Tsutsui K, Hosoya O, Sano K, Tokunaga A (2001) Immunohistochemical analyses of DNA topoisomerase II isoforms in developing rat cerebellum. J Comp Neurol 431(2):228–239PubMedCrossRef
28.
go back to reference Tsutsui K, Tsutsui K, Sano K, Kikuchi A, Tokunaga A (2001) Involvement of DNA topoisomerase IIbeta in neuronal differentiation. J Biol Chem 276(8):5769–5778PubMedCrossRef Tsutsui K, Tsutsui K, Sano K, Kikuchi A, Tokunaga A (2001) Involvement of DNA topoisomerase IIbeta in neuronal differentiation. J Biol Chem 276(8):5769–5778PubMedCrossRef
29.
go back to reference Wang JC (2002) Cellular roles of DNA topoisomerases: a molecular perspective. Nat Rev Mol Cell Biol 3(6):430–440PubMedCrossRef Wang JC (2002) Cellular roles of DNA topoisomerases: a molecular perspective. Nat Rev Mol Cell Biol 3(6):430–440PubMedCrossRef
30.
go back to reference Watanabe M, Tsutsui K, Tsutsui K, Inoue Y (1994) Differential expressions of the topoisomerase II alpha and II beta mRNAs in developing rat brain. Neurosci Res 19(1):51–57PubMedCrossRef Watanabe M, Tsutsui K, Tsutsui K, Inoue Y (1994) Differential expressions of the topoisomerase II alpha and II beta mRNAs in developing rat brain. Neurosci Res 19(1):51–57PubMedCrossRef
31.
go back to reference Woodbury D, Schwarz EJ, Prockop DJ, Black IB (2000) Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 61(4):364–370PubMedCrossRef Woodbury D, Schwarz EJ, Prockop DJ, Black IB (2000) Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 61(4):364–370PubMedCrossRef
32.
go back to reference Yang X, Li W, Prescott ED, Burden SJ, Wang JC (2000) DNA topoisomerase IIbeta and neural development. Science 287(5450):131–134PubMedCrossRef Yang X, Li W, Prescott ED, Burden SJ, Wang JC (2000) DNA topoisomerase IIbeta and neural development. Science 287(5450):131–134PubMedCrossRef
Metadata
Title
DNA topoisomerase IIβ as a molecular switch in neural differentiation of mesenchymal stem cells
Authors
Sevim Isik
Merve Zaim
Mehmet Taha Yildiz
Yesim Negis
Tuba Kunduraci
Nihal Karakas
Gulsum Arikan
Guven Cetin
Publication date
01-02-2015
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 2/2015
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-014-2209-7

Other articles of this Issue 2/2015

Annals of Hematology 2/2015 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.